Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

CDK1 protein offers clues to which breast cancers will resist targeted therapy

Researchers at the Garvan Institute of Medical Research have discovered that the activity of a protein called CDK1 in breast cancers is linked to how they respond to a common therapy—an insight that could inform more personalized treatment approaches for patients.

CDK1 protein offers clues to which breast cancers will resist targeted therapy

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Friday 30 October →